Ying Jiang

Ying Jiang

Auto-generated profile, based on publicly available information

Ying Jiang

Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
ZLZhao-Nan Liu
Zhao-Nan Liu
YJYing Jiang
Ying Jiang
XLXuan-Qi Liu
Xuan-Qi Liu
MYMeng-Meng Yang
Meng-Meng Yang
CCCheng Chen
Cheng Chen
QLQiong Luo
Qiong Luo
Gestational diabetes mellitus (GDM) is a common pregnancy complication which is normally diagnosed in the second trimester of gestation. With an increasing incidence, GDM poses a significant threat to maternal and offspring health. Therefore, we need a deeper understanding of GDM pathophysiology and novel investigation on the diagnosis and treatment for GDM. MicroRNAs (miRNAs), a class of endogenic small noncoding RNAs with a length of approximately 19-24 nucleotides, have been reported to exert their function in gene expression by binding to proteins or being enclosed in membranous vesicles, such as exosomes. Studies have investigated the roles of miRNAs in the pathophysiological mechanism of GDM and their potential as noninvasive biological candidates for the management of GDM, including diagnosis and treatment. This review is aimed at summarizing the pathophysiological significance of miRNAs in GDM development and their potential function in GDM clinical diagnosis and therapeutic approach. In this review, we summarized an integrated expressional profile and the pathophysiological significance of placental exosomes and associated miRNAs, as well as other plasma miRNAs such as exo-AT. Furthermore, we also discussed the practical application of exosomes in GDM postpartum outcomes and the potential function of several miRNAs as therapeutic target in the GDM pathological pathway, thus providing a novel clinical insight of these biological signatures into GDM therapeutic approach.

12 January 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
YYYue You
Yue You
FBFangfang Bi
Fangfang Bi
YJYing Jiang
Ying Jiang
YXYe‐Tao Xu
Ye‐Tao Xu
YAYuan‐Yuan An
Yuan‐Yuan An
QYQing Yang
Qing Yang
Breast cancer 1 (BRCA1) and autophagy both play a significant role in drug resistance. However, little is known about the dynamic cross talk between BRCA1 and autophagy in the regulation of drug sensitivity. Here, we investigated the drug resistance‐associated regulation of BRCA1 in epithelial ovarian cancer stem cells (EOCSCs). The results indicated that BRCA1 could regulate drug resistance in EOCSCs. Autophagy played a significant role in the stemness maintenance and was a key mechanism underlying the survival against chemotherapy in EOCSCs. Further investigation found that BRCA1 could regulate drug resistance of EOCSCs through autophagy. Meanwhile, changes in the level of autophagy provided feedback regarding the expression of BRCA1. Inhibition of autophagy activity could effectively reduce the resistance of EOCSCs caused by BRCA1. In addition, BRCA1 was able to regulate cellular apoptosis and cell cycle progression under the action of cisplatin through autophagy, indirectly affecting the drug sensitivity of EOCSCs. The present results highlight a novel relationship between BRCA1 and autophagy, which may provide insight into the etiology of BRCA1‐associated ovarian cancer, and improve our understanding of resistance mechanisms in ovarian cancer.

1 June 2020 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
JLJinru Lin
Jinru Lin
YJYing Jiang
Ying Jiang
YLYingmei Luo
Yingmei Luo
HGHao Guo
Hao Guo
CHChaobo Huang
Chaobo Huang
YCYi Cao
Yi Cao

15 December 2008 in Journal of Endodontics
Verified
Journal Article
Closed access
PDF file
QZQing-Hua Zheng
Qing-Hua Zheng
XZXuedong Zhou
Xuedong Zhou
YJYing Jiang
Ying Jiang
TSTuo-Qi Sun
Tuo-Qi Sun
CLCheng-Xia Liu
Cheng-Xia Liu
HDHuang Dingming
Huang Dingming

4 March 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
HZHong Zhu
Hong Zhu
SLSisi Luo
Sisi Luo
CLCenxi Liu
Cenxi Liu
YCYi Cheng
Yi Cheng
ZRZhuoran Ren
Zhuoran Ren
GDGuolian Ding
Guolian Ding
Gestational diabetes mellitus (GDM) can increase the risk for diabetes in offspring, but the mechanisms underlying the effects of intrauterine hyperglycemia (IHG) on the fetus remain unknown. Here, we show that IHG down-regulated DNA demethylases TET2/3 in fetal pancreatic islets, increased DNA methylation of γ-aminobutyric acid (GABA) synthesis gene Gad1 , suppressed Gad1 expression, and elevated somatostatin (SST) protein in the pancreas in mice. Pancreas-specific double knockout (DKO) of Tet2/3 recapitulates the IHG effects, causing Gad1 hypermethylation and expression down-regulation, alongside impaired insulin secretion and glucose tolerance. Metabolomic analysis revealed that IHG and Tet2/3 DKO reduced pancreatic GABA content. Gestational dietary GABA supplementation improved metabolic defects in both IHG and Tet2/3 DKO models. scRNA-seq analysis of pancreatic islets showed that IHG or Tet2/3 DKO down-regulated the β cell signature, whereas up-regulating δ cell–related genes, particularly Sst , led to the emergence of an Ins2/Sst double-positive cell population. β cell–specific deletion of Sst rescued IHG-induced metabolic defects. In humans, GDM was associated with reduced GABA content in the umbilical arterial blood. These results uncover an epigenetically controlled pancreatic GABA-SST signaling pathway that may contribute to the GDM-induced increase in offspring diabetes risk and identify dietary GABA supplementation as a potential interventional strategy.